NanoViricides Inc. (NNVC)

[arvitar]

“Required GLP Safety/Toxicology Studies of NV-CoV-2 Completed”

Assuming they can say the same thing for the required CMC work, there’s absolutely nothing stopping them from submitting an IND application and starting Phase-1 studies before end of year.

If I were given 15 minutes to present to investors, that would be the one point I’d emphasize. It’s the one milestone that would put them ahead of the hundreds of micrcrap biowrecks heading nowhere.

But it’s not even on the the list of ten “presentation highlights”.